ESS Tech Transitions to OTC Trading Platform
ESS Tech, Inc. (GWH) filed an SEC Form 8-K — Regulation FD Disclosure. ESS Tech Transitions to OTC Trading Platform Company Intends to Request Review of NYSE Regulation Determination Within Required Ten-Business-Day Period ESS Remains an SEC Reporting Company and Continues to Focus on all Strategic Transaction Opportunities WILSONVILLE, Ore. — Octob
How this was made
The 30-second read
Why it matters
The filing is the first public disclosure of the delisting and OTC transition, creating immediate uncertainty for investors.
Market read
The announcement is a primary corporate action that can trigger price volatility and liquidity concerns for the stock.
What to watch
Potential for a reverse split or a private placement that could stabilize the share price despite delisting.
Background
ESS Tech, a provider of non‑lithium energy storage, received an NYSE notice of suspension for not meeting the $15 M market‑cap requirement and announced a move to OTC trading.
Ticker impact
SEC 8‑K reports ESS Tech’s NYSE suspension and transition to OTC trading under GWHT, a new material corporate event.
downward pressure as investors price in reduced liquidity and compliance uncertainty
The company lost NYSE listing, will trade OTC; such events historically trigger sell‑offs, especially for micro‑caps.
Market effects
Highlights compliance risk for other small‑cap energy storage firms; may prompt review of listing standards.
Limited to U.S. OTC market participants; no broad regional effect.
Minimal; primarily affects ESS Tech shareholders and OTC traders.
Counterpoint
If the company secures a strategic transaction quickly, the OTC discount could narrow, offering a short‑term buying opportunity.
Key entities
- CompanyESS Tech, Inc.
Issuer of the 8‑K filing; transitioning from NYSE to OTC.
- ExecutiveDrew Buckley
CEO of ESS Tech, quoted on the transition.



